Novel peptides for the diagnosis of schizophrenia

Details for Australian Patent Application No. 2002241232 (hide)

Owner Yeda Research and Development Co. Ltd.

Inventors Deckmann, Michael

Agent Acumen Intellectual Property

Pub. Number AU-B-2002241232

PCT Pub. Number WO2002/074793

Priority 142159 21.03.01 IL; 60/278,659 21.03.01 US

Filing date 21 March 2002

Wipo publication date 3 October 2002

Acceptance publication date 1 February 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002241232

1 February 2007 Application Accepted

  Published as AU-B-2002241232

31 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002241233-A METHOD AND SYSTEM FOR TRANSMITTING AND/OR RECEIVING AUDIO SIGNALS WITH A DESIRED DIRECTION

2002241231-DEVICE FOR DETERMINING HEMODYNAMIC STATE